Neuropsychomotor Functions in Children With Autism Spectrum Disorder

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Centre Hospitalier Esquirol
Sponsor:
Information provided by (Responsible Party):
Bertrand Olliac, Centre Hospitalier Esquirol
ClinicalTrials.gov Identifier:
NCT01987037
First received: November 12, 2013
Last updated: July 23, 2014
Last verified: July 2014
  Purpose

The aim of the study is to describe the feasibility of the passation of the assessment battery of psychomotor functions tests (NP-MOT) in children aged 4 to 11 years with a diagnosis of autism spectrum disorder: number and type of evaluable events, number and type of tests with a deficit compared to the standard results.


Condition Intervention
Autism Spectrum Disorder
Behavioral: neuropsychomotor assessment

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Neuropsychomotor Functions in Children With Autism Spectrum Disorder

Resource links provided by NLM:


Further study details as provided by Centre Hospitalier Esquirol:

Primary Outcome Measures:
  • results to the NP-MOT tests battery [ Time Frame: one day ] [ Designated as safety issue: No ]

    the NP-MOT battery tests include several tests to evaluate 9 motor functions (muscle tone, gross motor, laterality, fine-digit movement, digital tactile gnosis, hand-eye skill, body spatial orientation, pace, auditory attention) with 48 subtests.

    We describe:

    number and type of evaluable tests, number and type of tests with results with 1 Standard Deviation different from the standard results.

    number and type of tests with results with 2 Standard Deviation different from the standard results.



Estimated Enrollment: 40
Study Start Date: October 2013
Estimated Study Completion Date: February 2016
Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
tests evaluation
children with autism spectrum disorder subjected to the NP-MOT tests
Behavioral: neuropsychomotor assessment
Children with autism spectrum disorders pass a specific battery test (NP-MOT) for a neuropsychomotor assessment. This neuropsychomotor assessment is administered in a half-day maximum. This battery aims to investigate passive muscle tone (shoulders, limbs, and trunk), standing and synkinesia, static and dynamic balance, tonic laterality (extensibility and dangling of hands and feet to identify the tonic dominant side), laterality of use, fine-digit movements, digital tactile gnosis, and body spatial integration (knowing left from right: for oneself and that of others, and with regard to objects).

Detailed Description:

After informed consent obtention, the children will be submitted to the different tests of the battery to evaluate the psychomotor functions. The results will be compared with other data collected from the routine practise : socio-demographic data, medical and developmental antecedents,psychological tests (KABC II, Rey test, London Tower test, ...), psychomotor evaluation (MABC, evaluation of manual praxis, visual abilities, Frostig test), understanding data (N-EEL test), neuropediatric examination, clinical assessment (ADI-R, CARS).

The use of this battery allows this fine discriminative assessment of the psychomotor functions involved in the movement. Exploring each function will allow to take into account qualitative and quantitative aspects of the movement in every aspects, and this is not applied in the routine care until now. Calibration for each event can explore each function independently of each other, and will provide information to determine any specific developmental characteristics improve care.

  Eligibility

Ages Eligible for Study:   4 Years to 11 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

children attended in the Centre Hospitalier Esquirol and the CRA (Autism Reference Center) in Limousin, France, for suspiscion of autism

Criteria

Inclusion Criteria:

  • informed consent from the parents or the legal representative
  • age 4 to 11
  • autism spectrum disorder diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition- text revised

Exclusion Criteria:

  • bad understanding of the french language
  • motor disability from lesion or accidental origin, proved genetic or neurologic disease
  • deafness, blindness
  • parents with administrative or judiciary protection, and without health insurance
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01987037

Contacts
Contact: Aude Paquet 0033555431010 ext 3185 audepaquet@gmail.com
Contact: Murielle Girard, PhD 0033555431028 murielle.girard@ch-esquirol-limoges.fr

Locations
France
Centre Hospitalier esquirol Recruiting
Limoges, France
Contact: Aude Paquet    0033555431010 ext 3185    audepaquet@gmail.com   
Centre de Ressources Autisme Limousin Recruiting
Limoges, France
Sponsors and Collaborators
Centre Hospitalier Esquirol
  More Information

Publications:
Responsible Party: Bertrand Olliac, M.D Ph.D., Centre Hospitalier Esquirol
ClinicalTrials.gov Identifier: NCT01987037     History of Changes
Other Study ID Numbers: 2013-A00644-41
Study First Received: November 12, 2013
Last Updated: July 23, 2014
Health Authority: France: Committee for the Protection of Personnes
France: Agence Nationale de Sécurité du Médicament et des produits de santé

Keywords provided by Centre Hospitalier Esquirol:
autism spectrum disorder
neuropsychomotor assessment
NP-MOT
motor skills
gross motor

Additional relevant MeSH terms:
Autistic Disorder
Child Development Disorders, Pervasive
Mental Disorders Diagnosed in Childhood
Mental Disorders

ClinicalTrials.gov processed this record on July 28, 2014